According to a report, a survey of 346 doctors revealed that 89% of them have seen a recent increase in patients requesting ...

Although the studies are few, some research has also shown staying on the drugs long term may raise the risk of developing the bone-thinning condition osteoporosis by up to 20 per cent.

Different reasons have been offered by the Trump Administration for tariffs on Canada and Mexico, but the President’s advisers have honed in on one reason specifically: Fentanyl is being shipped ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

The new daily pill, approved in England, for the treatment of endometriosis works by blocking the hormones that make the ...

An abundance of data show that SSRIs, a class of drugs commonly used as antidepressants, are effective, though, like any drug, they have risks.

They are just a small fraction of what could be 300,000 people working in similar operations across the region, and their ...

Since the FDA’s groundbreaking approval of Zarxio in 2015, the US biosimilars market has surged to 67 approvals across 18 ...

Of the 100 million people in the world with cirrhosis (scarring of the liver), about three million are hospitalised with an episode of confusion or coma that is associated with elevated ammonia levels ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

The NHS could prevent thousands more heart attacks and strokes every year by offering everyone in the UK aged 50 and over a ...

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...